Skip to content

house · Committee report

H. Rept. 119-734

NIH IMPLEMENTING A MATERNAL HEALTH AND PREGNANCY OUTCOMES VISION FOR EVERYONE ACT

2026-07-09

Committees

Associated legislation

Text

Purpose and Summary

H.R. 6238, introduced on November 20, 2025, by Representatives Lauren Underwood (D-IL) and Brian Fitzpatrick (R-PA), authorizes the Implementing a Maternal Health and Pregnancy Outcomes Vision for Everyone (IMPROVE) Initiative within the National Institutes of Health (NIH) for fiscal years (FY) 2026 through 2031. This legislation advances maternal health research to reduce preventable causes of maternal mortality and severe maternal morbidity.

Background and Need for Legislation

In 2024, 649 women in the U.S. died from pregnancy-related causes.\1\ Severe maternal morbidity (SMM)--serious and unexpected outcomes associated with pregnancy--annually impact 30,000 in the U.S. and rate of SMM has increased over the past decade.\2\ The Centers for Disease Control and Prevention estimates that over 80 percent of pregnancy-related death and about half of SMM events could be preventable.\3\ Women in the United States face higher maternal mortality rates than other high-income nations.\4\ Black and Native American women, as well as individuals in rural areas, are disproportionately affected by severe maternal morbidity and mortality.\5\ --------------------------------------------------------------------------- \1\U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, Report to Congress, Addressing the Maternal Health Crisis in the United States: An Update from the U.S. Department of Health and Human Services (Jul. 2024), https://aspe.hhs.gov/sites/default/files/documents/ 3c79dd97c5a9330173bd033f30fb7ba6/rtc- maternal-health.pdf. \2\Id. \3\Id. \4\Evan D. Gumas et al., Maternal and Child Mortality: How Do U.S. States Compare Internationally?, The Commonwealth Fund (Oct. 1, 2025), https://www.commonwealthfund.org/ publications/issue-briefs/2025/oct/maternal-child-mortality-how-do-us- states-compare- internationally?utm_source=newsletter&utm_medium=email&utm_campaign=news letter_ axiosvitals&stream=top. \5\U.S. Department of Health and Human Services, National Institutes of Health, IMPROVE Initiative, Implementing a Maternal health and Pregnancy Outcomes Vision for Everyone (IMPROVE) Initiative (last accessed Jun. 2026), https://www.nichd.nih.gov/research/ supported/IMPROVE. --------------------------------------------------------------------------- Access to maternal health care has been a challenge for many women as roughly 35 percent of U.S. counties are considered maternity care deserts and over half of U.S. counties lacked a hospital or birth center providing obstetric care.\6\ Further, reduced access to obstetric care has been correlated with higher rates of maternal illness and death.\7\ Launched by the NIH in 2019, the IMPROVE Initiative lacked a dedicated and consistent funding source, threatening long-term research outcomes. The act provides an authorization for continuous annual funding to support sustained, multi-year research. H.R. 6238 authorizes the IMPROVE Initiative and funding to advance maternal health research, support the integration of disproportionally affected populations affected by high rates of maternal morbidity and mortality, and ultimately reduce preventable causes of maternal mortality and morbidity. --------------------------------------------------------------------------- \6\Health Resources & Services Administration, How We Improve Maternal Health (Feb. 2025), https://www.hrsa.gov/maternal-health#3. \7\Sebastian Z. Ramos et al., Maternal care deserts and risk of maternal morbidity in term pregnancies, American Journal of Obstetrics & Gynecology (Jan. 2026), https://www.ajogmfm.org/article/S2589- 9333(25)00220-4/abstract. ---------------------------------------------------------------------------

Committee Action

On April 21, 2026, the Subcommittee on Health held a hearing related to H.R. 6238. The title of the hearing was, ``The Fiscal Year 2027 Department of Health and Human Services Budget.'' The Subcommittee received testimony from: The Honorable Robert F. Kennedy, Jr., Secretary, U.S. Department of Health and Human Services. On May 21, 2026, the full Committee on Energy and Commerce met in open markup session and ordered H.R. 6238, as amended, favorably reported to the House by a record vote of 46 yeas and 0 nays.

Committee Votes

Clause 3(b) of rule XIII requires the Committee to list the record votes on the motion to report legislation and amendments thereto. The following reflects the record votes taken during the Committee consideration: [GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT] Oversight Findings and Recommendations Pursuant to clause 2(b)(1) of rule X and clause 3(c)(1) of rule XIII, the Committee held a hearing and made findings that are reflected in this report. New Budget Authority, Entitlement Authority, and Tax Expenditures Pursuant to clause 3(c)(2) of rule XIII, the Committee finds that H.R. 6238 would result in no new or increased budget authority, entitlement authority, or tax expenditures or revenues.

Congressional Budget Office Estimate

Pursuant to clause 3(c)(3) of rule XIII, at the time this report was filed, the cost estimate prepared by the Director of the Congressional Budget Office pursuant to section 402 of the Congressional Budget Act of 1974 was not available. Federal Mandates Statement The Committee adopts as its own the estimate of Federal mandates prepared by the Director of the Congressional Budget Office pursuant to section 423 of the Unfunded Mandates Reform Act. Statement of General Performance Goals and Objectives Pursuant to clause 3(c)(4) of rule XIII, the general performance goal or objective of this legislation is to support research to reduce preventable maternal deaths and severe maternal morbidity, improve maternal health at every stage of pregnancy, and address disparities in maternal outcomes. Duplication of Federal Programs Pursuant to clause 3(c)(5) of rule XIII, no provision of H.R. 6238 is known to be duplicative of another Federal program, including any program that was included in a report to Congress pursuant to section 21 of Public Law 111-139 or the most recent Catalog of Federal Domestic Assistance. Related Committee and Subcommittee Hearings Pursuant to clause 3(c)(6) of rule XIII, the following related hearing was used to develop or consider H.R. 6238: On April 21, 2026, the Subcommittee on Health held a hearing on H.R. 6238. The title of the hearing was ``The Fiscal Year 2027 Department of Health and Human Services Budget.'' The Subcommittee received testimony from: The Honorable Robert F. Kennedy, Jr., Secretary, U.S. Department of Health and Human Services. Committee Cost Estimate Pursuant to clause 3(d)(1) of rule XIII, the Committee adopts as its own the cost estimate prepared by the Director of the Congressional Budget Office pursuant to section 402 of the Congressional Budget Act of 1974. At the time this report was filed, the estimate was not available. Earmark, Limited Tax Benefits, and Limited Tariff Benefits Pursuant to clause 9(e), 9(f), and 9(g) of rule XXI, the Committee finds that H.R. 6238 contains no earmarks, limited tax benefits, or limited tariff benefits. Advisory Committee Statement No advisory committees within the meaning of section 5(b) of the Federal Advisory Committee Act were created by this legislation. Applicability to Legislative Branch The Committee finds that the legislation does not relate to the terms and conditions of employment or access to public services or accommodations within the meaning of section 102(b)(3) of the Congressional Accountability Act. Section-by-Section Analysis of the Legislation Section 1. Short title Section 1 provides the short title of ``NIH Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone'' or the ``NIH IMPROVE Act.'' Section 2. IMPROVE Initiative Section 2 reauthorizes the IMPROVE Initiative through 2031. The IMPROVE Initiative promotes research into the reduction of preventable causes driving maternal mortality and severe maternal morbidity and health disparities in maternal health outcomes, as well as improve women's health throughout the timespan of their pregnancy. Changes in Existing Law Made by the Bill, as Reported In compliance with clause 3(e) of rule XIII of the Rules of the House of Representatives, changes in existing law made by the bill, as reported, are shown as follows (new matter is printed in italics and existing law in which no change is proposed is shown in roman): PUBLIC HEALTH SERVICE ACT * * * * * * * TITLE IV--NATIONAL RESEARCH INSTITUTES * * * * * * * Part B--General Provisions Respecting National Research Institutes * * * * * * * SEC. 409K. IMPROVE INITIATIVE. (a) In General.--The Director of NIH shall continue to carry out a program to improve maternal health outcomes, to be known as the Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone Initiative or the ``IMPROVE Initiative'' (referred to in this section as the ``Initiative''). (b) Objectives.--The Initiative shall-- (1) advance research to-- (A) reduce preventable causes of maternal mortality and severe maternal morbidity; (B) reduce health disparities related to maternal health outcomes, including such disparities associated with populations with disproportionately high rates of maternal mortality and severe maternal morbidity relative to the national rate; and (C) improve health for pregnant and postpartum women before, during, and after pregnancy; (2) use an integrated approach to understand the factors, including biological, behavioral, and other factors, that affect maternal mortality and severe maternal morbidity by building an evidence base for improved outcomes in specific regions of the United States; and (3) target health disparities associated with maternal mortality and severe maternal morbidity by-- (A) implementing and evaluating community- based interventions for disproportionately affected women; and (B) identifying risk factors and the underlying biological mechanisms associated with leading causes of maternal mortality and severe maternal morbidity in the United States. (c) Implementation.--The Director of NIH may award grants or enter into contracts, cooperative agreements, or other transactions to carry out this section. (d) Authorization of Appropriations.--There is authorized to be appropriated to carry out this section $63,400,000 for each of fiscal years 2026 through 2030. * * * * * * * [all]

Source: https://api.congress.gov/v3/committee-report/119/hrpt/734